Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

The role of transcutaneous electrical stimulation of Neiguan anti-emetic acupuncture point in controlling sickness after cancer chemotherapy
McMillan C, Dundee JW
Physiotherapy 1991 Jul;77(7):499-502
clinical trial
1/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: No; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: No; Point estimates and variability: No. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

The already proven anti-emetic action of P6 (Neiguan) acupuncture has been used with success in patients having cancer chemotherapy. The more patient-acceptable alternative to needling, transcutaneous electrical stimulation of P6, has been evaluated using a simple, custom-built stimulator and large surface electrodes. This can be administered by the patient and preliminary findings show it to be a useful adjunct to both the older anti-emetics and the new 5 HT3 antagonist, ondansetron.

Full text (sometimes free) may be available at these link(s):      help